نتائج البحث

Evaluating the Effect of Standard-of-care Erythropoiesis-stimulating Agents on Forearm Blood Flow in Nondialysis-dependent Subjects With Anaemia Associated With Chronic Kidney Disease. (OPERA-CKD)

• Authors : GlaxoSmithKline; Joseph Cheriyan, MD, Consultant Physician & Clinical Pharmacologist/Assoc Lecturer

• Source: An Observational, Open-label Pilot Study to Evaluate the Effect of Standard-of-care Erythropoiesis-stimulating

تفاصيل العنوان

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

• Authors : Feby Rasmy Khalifa Makar, Doctor

• Source: Prevalence of Erthropoietin Stimulating Agents Hyporesponsiveness and Its Correlation With Cardiovascular Morbidities in Hemodialysis

تفاصيل العنوان

Zinc Supplementation Enhances the Hematopoietic Activity of Erythropoiesis-Stimulating Agents but Not Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors.

• Authors : Takahashi, Akira¹

Subjects: *HEMATOPOIETIC agents; *SCIENTIFIC observation; *HEMOGLOBINS

• Source: Nutrients. Feb2024, Vol. 16 Issue 4, p520. 14p.

تفاصيل العنوان

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents (CORRECTION)

• Source: A Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Once Daily Oral Vadadustat for The Treatment of Pediatric Subjects With Anemia of Chronic Kidney Disease Naive to

تفاصيل العنوان

Impact of anemia requiring transfusion or erythropoiesis-stimulating agents on new-onset cardiovascular events and mortality after continuous renal replacement therapy

• Authors : Junseok Jeon; Danbee Kang; Hyejeong Park

Subjects: Critical illness; Anemia; Continuous renal replacement therapy

• Source: Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)

تفاصيل العنوان

Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis.

• Authors : Karimi, Zahra¹ (AUTHOR); Raeisi Shahraki, Hadi² (AUTHOR); Mohammadian-Hafshejani, Abdollah³ (AUTHOR)

Subjects: *HEMODIALYSIS patients; *CLINICAL trials; *AGE groups

• Source: PLoS ONE. 11/9/2023, Vol. 18 Issue 11, p1-23. 23p.

تفاصيل العنوان

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes:the HOVON89 trial

• Authors : van de Loosdrecht, A. A.; Cremers, E. M.P.; Alhan, C.

Subjects: dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; article; article

• Source: van de Loosdrecht , A A , Cremers , E M P , Alhan , C , Duetz , C , in ’t Hout , F E M , Visser-Wisselaar , H A , Chitu , D A , Verbrugge , A , Cunha , S M , Ossenkoppele , G J , Janssen , J J W M ,

تفاصيل العنوان

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome

• Authors : Garelius, HKG; Johnston, WT; Smith, AG

Subjects: Medicin och hälsovetenskap

• Source: Journal of internal medicine. 281(3):284-299

تفاصيل العنوان

Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

• Authors : Salma Magdy Abdelfattah, Teaching Assistant

• Source: Short Versus Long-Acting Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis

تفاصيل العنوان

Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)

• Authors : Otsuka Pharmaceutical Development & Commercialization, Inc.

• Source: Phase 3b, Randomized, Open-label, Active-controlled Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in

تفاصيل العنوان